These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 15820939)
21. Sildenafil for pulmonary hypertension. Lee AJ; Chiao TB; Tsang MP Ann Pharmacother; 2005 May; 39(5):869-84. PubMed ID: 15827074 [TBL] [Abstract][Full Text] [Related]
22. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction. Sheth A; Park JE; Ong YE; Ho TB; Madden BP Vascul Pharmacol; 2005 Jan; 42(2):41-5. PubMed ID: 15722248 [TBL] [Abstract][Full Text] [Related]
23. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease? Madden BP; Sheth A; Wilde M; Ong YE Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899 [TBL] [Abstract][Full Text] [Related]
24. Sildenafil in the management of primary pulmonary hypertension. Singh B; Gupta R; Punj V; Ghose T; Sapra R; Grover DN; Kaul U Indian Heart J; 2002; 54(3):297-300. PubMed ID: 12216929 [TBL] [Abstract][Full Text] [Related]
25. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension. Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512 [TBL] [Abstract][Full Text] [Related]
26. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618 [TBL] [Abstract][Full Text] [Related]
27. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis]. Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963 [TBL] [Abstract][Full Text] [Related]
28. Use of oral sildenafil in patients with irreversible pulmonary hypertension not eligible for heart transplantation. Gómez-Moreno S; Lage E; Hernández A; Campos A; Cabezón S; Ordóñez A; Hinojosa R Transplant Proc; 2005 Apr; 37(3):1550-1. PubMed ID: 15866670 [TBL] [Abstract][Full Text] [Related]
29. Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension. Onen ZP; Akkoca Yildiz O; Eriş Gülbay B; Karabiyikoğlu G Tuberk Toraks; 2006; 54(2):177-81. PubMed ID: 16924576 [TBL] [Abstract][Full Text] [Related]
30. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure. Maruszewski M; Zakliczyński M; Przybylski R; Kucewicz-Czech E; Zembala M Transplant Proc; 2007 Nov; 39(9):2850-2. PubMed ID: 18021999 [TBL] [Abstract][Full Text] [Related]
32. Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery. Shim JK; Choi YS; Oh YJ; Kim DH; Hong YW; Kwak YL J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1420-5. PubMed ID: 17140970 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and optimal dose of sildenafil in primary pulmonary hypertension. Chockalingam A; Gnanavelu G; Venkatesan S; Elangovan S; Jagannathan V; Subramaniam T; Alagesan R; Dorairajan S Int J Cardiol; 2005 Mar; 99(1):91-5. PubMed ID: 15721505 [TBL] [Abstract][Full Text] [Related]
34. [Oral sildenafil citrate as an effective alternate in the treatment of postoperative pulmonary hypertensive crisis after congenital heart surgery]. Nemoto S; Umehara E; Ikeda T; Doi T; Hiraumi Y; Yokoyama S; Inui K; Sakakibara Y; Koyama T; Ohno N; Nishina T; Komeda M Kyobu Geka; 2004 Aug; 57(9):842-5. PubMed ID: 15366567 [TBL] [Abstract][Full Text] [Related]
35. Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates. Zakliczynski M; Maruszewski M; Pyka L; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M Transplant Proc; 2007 Nov; 39(9):2856-8. PubMed ID: 18022001 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure. Alaeddini J; Uber PA; Park MH; Scott RL; Ventura HO; Mehra MR Am J Cardiol; 2004 Dec; 94(11):1475-7. PubMed ID: 15566933 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension. Gomberg-Maitland M; McLaughlin V; Gulati M; Rich S Am J Cardiol; 2005 Nov; 96(9):1334-6. PubMed ID: 16253609 [TBL] [Abstract][Full Text] [Related]
38. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension. Noori S; Friedlich P; Wong P; Garingo A; Seri I Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658 [TBL] [Abstract][Full Text] [Related]
39. Pulmonary hypertension in patients with hemoglobinopathies: could a mechanism for dysfunction provide an avenue for novel therapeutics? Lin EE; Gladwin MT; Machado RF Haematologica; 2005 Apr; 90(4):441-4. PubMed ID: 15820937 [No Abstract] [Full Text] [Related]
40. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. Ghofrani HA; Pepke-Zaba J; Barbera JA; Channick R; Keogh AM; Gomez-Sanchez MA; Kneussl M; Grimminger F J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):68S-72S. PubMed ID: 15194181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]